Fragmin injection
From Wikidoc - Reading time: 3 minEditor-In-Chief: C. Michael Gibson, M.S., M.D. [1]{{{authorTag}}}
For information about {{{genericName}}}, click here.
Disclaimer
Overview
Fragmin injection is a {{{drugClass}}} drug that is FDA approved for the treatment of {{{indication}}}. Adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
Pediatric Indications and Dosage
Contraindications
Warnings
Adverse Reactions
Drug Interactions
Use in Specific Populations
Routes and Preparations
IV Compatibility
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Information
Patient Information from FDA
Patient Information from NLM
Look-Alike Drug Names
Price
Drug Shortage
Adult Indications and Dosage
Below is the code to be placed on the Adult Indications and Dosage Microchapeter:
__NOTOC__
{{Labeltemplate}}
{{CMG}}
===FDA-Labeled Indications and Dosage (Adult)===
123
===Off-Label Use and Dosage (Adult)===
{{{offLabelAdult}}}
{{DrugReflist}}Pediatric Indications and Dosage
Below is the code to be placed on the Adult Indications and Dosage Microchapeter:
__NOTOC__
{{Labeltemplate}}
{{CMG}}
===FDA-Labeled Indications and Dosage (Pediatric)===
12312312312312
===Off-Label Use and Dosage (Pediatric)===
{{{offLabelPed}}}
{{DrugReflist}}
Use in Specific Populations
Below is the code to be placed on the Drug Interaction Microchapter:
__NOTOC__
{{Labeltemplate}}
{{CMG}}
===Pregnancy===
: '''[[Pregnancy category#United States|Pregnancy Category (FDA)]]'''
There is no FDA guidance on usage of {{BASEPAGENAME}} in women who are pregnant.
:'''[[Pregnancy category#Australia|Pregnancy Category (AUS)]]'''
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{BASEPAGENAME}} in women who are pregnant.
===Labor and Delivery===
There is no FDA guidance on use of {{BASEPAGENAME}} during labor and delivery.
===Nursing Mothers===
There is no FDA guidance on the use of {{BASEPAGENAME}} in women who are nursing.
===Pediatric Use===
There is no FDA guidance on the use of {{BASEPAGENAME}} in pediatric settings.
===Geriatic Use===
There is no FDA guidance on the use of {{BASEPAGENAME}} in geriatric settings.
===Gender===
There is no FDA guidance on the use of {{BASEPAGENAME}} with respect to specific gender populations.
===Race===
There is no FDA guidance on the use of {BASEPAGENAME}} with respect to specific racial populations.
===Renal Impairment===
There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with renal impairment.
===Hepatic Impairment===
There is no FDA guidance on the use of {{BASEPAGENAME}} in patients with hepatic impairment.
===Females of Reproductive Potential and Males===
There is no FDA guidance on the use of {{BASEPAGENAME}} in women of reproductive potentials and males.
===Immunocompromised Patients===
There is no FDA guidance one the use of {{BASEPAGENAME}} in patients who are immunocompromised.
{{DrugReflist}}
Overdose
Below is the code to be placed on the Overdose Microchapter:
__NOTOC__
{{Labeltemplate}}
{{CMG}}
'''Please contact the National Poison Help hotline (1-800-222-1222) immediately if there is suspicion of drug poisoning or overdose.'''
===Overdose===
{{{overdose}}}
{{DrugReflist}}Pharmacology
Below is the code to be placed on the Pharmacology Microchapter:
__NOTOC__
{{Labeltemplate}}
{{CMG}}
===Mechanism of Action===
{{{mechAction}}}
===Structure===
{{{structure}}}
===Pharmacodynamics===
{{{PD}}}
===Pharmacokinetics===
{{{PK}}}
===Nonclinical Toxicology===
{{{nonClinToxic}}}
{{DrugReflist}}
Original source: https://wikidoc.org/Fragmin injection
Status: article is cached
EncycloReader
is supported by the 
KSF